EDANUS
Edanus is a pharmaceutical product marketed by Seginus Cure Pharma. It is supplied for professional use and distributed through authorized healthcare channels.
Advanced Neuroprotection (Edaravone Injection 20 ml) is a high-quality neuroprotective formulation designed to help manage oxidative stress associated with neurological conditions. It contains Edaravone, a potent free radical scavenger known for protecting brain cells from damage caused by oxidative stress and ischemia. Manufactured under strict quality control standards, it ensures reliable efficacy, purity, and stability.
It works by reducing lipid peroxidation and oxidative neuronal injury, helping promote better recovery in patients suffering from acute ischemic stroke and other related neurological impairments. It is trusted by healthcare professionals for its fast action, high bioavailability, and consistent results.
Advantages
Neuroprotective Action: Protects neurons from oxidative stress and free radical-induced damage.
Rapid Therapeutic Response: Designed for quick onset and effective management of acute symptoms.
Clinically Backed Efficacy: Supported by research demonstrating improved neurological recovery outcomes.
High Purity Formulation: Produced using advanced pharmaceutical technology ensuring maximum stability and potency.
Stringent Quality Assurance: Manufactured in a GMP-certified facility with rigorous quality checks.
Key Indications
Acute Ischemic Stroke (as part of comprehensive stroke management)
Amyotrophic Lateral Sclerosis (ALS) – to slow functional decline
Neurodegenerative Disorders associated with oxidative neuronal damage
Cerebral Ischemia & Hypoxic Brain Injury (adjunct therapy)
Safety Advice & Precautions
Use only under the direction of a qualified healthcare provider.
Monitor liver and kidney function as advised by the physician.
Report any signs of allergic reaction, rash, or difficulty breathing
Not recommended during pregnancy or breastfeeding unless prescribed.
Disclaimer
This information is intended for educational and marketing purposes only and should not replace medical consultation. Edanus (Edaravone Injection 20 ml) should be used strictly as prescribed by a licensed medical practitioner. Always read the product leaflet before use.
Frequently Asked Questions (FAQs)
It is used primarily for neuroprotection in conditions like acute ischemic stroke and ALS, where oxidative stress contributes to neuronal damage.
It is administered intravenously by a healthcare professional as per prescribed protocol.
It is generally used as part of a comprehensive stroke management plan. Suitability depends on clinical evaluation by a physician.
Long-term use is guided by the treating neurologist based on patient condition and response.
EDANUS does not cure neurological diseases but helps reduce neuronal damage and slow disease progression.